Hearing Impaired: Clinical Trials

3 trials for Hearing Impaired, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 11Recruiting 1

Follow Hearing Impaired: new trials by email Literature Review of Hearing Impaired trials Research Report on Hearing Impaired

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
Functioning, Disability, and Quality of Life in the Adult Hearing Impaired
Hearing Aids - Hearing Impaired
Phase 2CompletedUS Department of Veterans Affairs3302001-07-012009-02-11
Measurement and Prediction of Outcomes of Amplification
Hearing - Hearing Impaired
Phase 2CompletedUS Department of Veterans Affairs1201999-10-012009-01-21

Narrower conditions

Hearing Loss (3)  ·  Auditory Diseases, Central (1)  ·  Hearing Disorders (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)

Broader conditions

Ear Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Hearing Disorders (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Language Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Retrocochlear Diseases (1)

Interventions

Clemastine (1)  ·  Hearing (1)  ·  Hearing Aids (1)  ·  Placebo Effect (1)

Sponsors

US Department of Veterans Affairs (2)  ·  University of Colorado, Denver (1)

Countries

United States (3)

Top investigators

Achim Klug, PhD (1)  ·  Harvey Abrams, PhD (1)  ·  John Fryer, Ph.D., Asst. Director (1)  ·  Nancy Rocheleau, Program Analyst (1)  ·  Samuel A Budoff, PhD, MS (1)

Results publications

PMID 16244757, PMID 16244758, PMID 16244759